Carolyn Wingate Hyde News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Carolyn wingate hyde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Carolyn Wingate Hyde Today - Breaking & Trending Today

Breakthrough study uncovers potential treatment of breast cancer through targeted drugs


Breakthrough study uncovers potential treatment of breast cancer through targeted drugs
Breakthrough study uncovers potential treatment of breast cancer through targeted drugs
Last Updated: Tue, Apr 27th, 2021, 10:20:08hrs
Washington [US], April 27 (ANI): A recent study led by researchers at the Virginia Commonwealth University (VCU) Massey Cancer Center found strong evidence that prolactin, a hormone responsible for breast growth and production of milk during pregnancy acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease.
Hormones have proteins on their cell surface called receptors that receive and send biological messages and regulate cell function. Through research published in the journal npj (Nature Partner Journals) Breast Cancer, VCU Massey Cancer Center researcher Charles Clevenger, M.D., PhD, and his lab discovered a new, altered form of the prolact ....

Carolyn Wingate Hyde , Charles Clevenger , Cancer Research , School Of Medicine , Department Of Pathology , Massey Cancer Center , Nature Partner Journals , Breast Cancer , Cancer Center , Carolyn Wingate Hyde Endowed Chair , Cancer Biology , Featured Article , புற்றுநோய் ஆராய்ச்சி , பள்ளி ஆஃப் மருந்து , துறை ஆஃப் நோயியல் , மஸ்ஸி புற்றுநோய் மையம் , இயற்கை கூட்டாளர் பத்திரிகைகள் , மார்பக புற்றுநோய் , புற்றுநோய் மையம் , புற்றுநோய் உயிரியல் , சிறப்பு கட்டுரை ,

Studies connect hormone to breast cancer and uncover potential for novel targeted drugs


Credit: VCU Massey Cancer Center
The hormone prolactin has long been understood to play a vital role in breast growth and development and the production of milk during pregnancy. But a pair of recent studies conducted at VCU Massey Cancer Center finds strong evidence that prolactin also acts as a major contributor to breast cancer development and that the hormone could inform the creation of targeted drugs to treat multiple forms of the disease.
Hormones have proteins on their cell surface called receptors that receive and send biological messages and regulate cell function. Through research published in
npj Breast Cancer, VCU Massey Cancer Center researcher Charles Clevenger, M.D., Ph.D., and his lab discovered a new, altered form of the prolactin receptor called the human prolactin receptor intermediate isoform (hPRLrI) that directly drives breast cancer. The researchers observed that this modified version of the prolactin receptor interacted with other forms of the ....

Jacqueline Grible , Tia Turner , Alicia Woock , Amy Olex , Charles Clevenger , Justin Craig , Michael Idowu , Carolyn Wingate Hyde , Chuck Harrell , Shannon Hedrick , Cancer Research , School Of Medicine , Department Of Pathology , Dianne Wright Center , Massey Cancer Center , Translational Research , Cancer Center , Breast Cancer , Carolyn Wingate Hyde Endowed Chair , Cancer Biology , Featured Article , Patricija Zot , தியா டர்னர் , ஆமி ஒலெக்ஷ , ஜஸ்டின் கிரேக் , மைக்கேல் இதோவு ,